John Spritzler

4.1k total citations
55 papers, 3.2k citations indexed

About

John Spritzler is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, John Spritzler has authored 55 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Virology, 33 papers in Infectious Diseases and 17 papers in Epidemiology. Recurrent topics in John Spritzler's work include HIV Research and Treatment (42 papers), HIV/AIDS Research and Interventions (25 papers) and HIV/AIDS drug development and treatment (21 papers). John Spritzler is often cited by papers focused on HIV Research and Treatment (42 papers), HIV/AIDS Research and Interventions (25 papers) and HIV/AIDS drug development and treatment (21 papers). John Spritzler collaborates with scholars based in United States, Canada and Japan. John Spritzler's co-authors include Alan Landay, Michael M. Lederman, Daniel R. Kuritzkes, Harold A. Kessler, Elizabeth Connick, Lawrence Fox, Richard B. Pollard, Jeffrey M. Jacobson, David M. Asmuth and Miriam Chernoff and has published in prestigious journals such as New England Journal of Medicine, Blood and PLoS ONE.

In The Last Decade

John Spritzler

55 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Spritzler United States	29	1.8k	1.4k	925	911	483	55	3.2k
S. A. Danner Netherlands	21	1.7k 0.9×	1.4k 0.9×	551 0.6×	636 0.7×	352 0.7×	46	2.6k
P T Schellekens Netherlands	23	1.8k 1.0×	1.2k 0.8×	1.1k 1.2×	683 0.7×	209 0.4×	52	2.7k
Jean‐Luc Pellegrin France	34	875 0.5×	1.1k 0.8×	1.1k 1.2×	691 0.8×	546 1.1×	124	4.0k
Jacques Leibowitch France	19	1.5k 0.8×	1.2k 0.9×	827 0.9×	701 0.8×	274 0.6×	35	2.5k
Jason D. Barbour United States	30	2.5k 1.3×	2.0k 1.4×	1.6k 1.7×	664 0.7×	430 0.9×	52	4.0k
Sigrid A. Otto Netherlands	29	2.6k 1.4×	1.1k 0.8×	3.1k 3.4×	1.1k 1.2×	434 0.9×	55	4.8k
Jean‐Daniel Lelièvre France	26	1.3k 0.7×	775 0.5×	1.3k 1.4×	556 0.6×	196 0.4×	101	2.7k
Deborah K. McMahon United States	29	3.0k 1.6×	3.0k 2.1×	595 0.6×	1.3k 1.4×	810 1.7×	85	4.5k
Hiroyu Hatano United States	28	2.5k 1.4×	1.9k 1.3×	1.2k 1.3×	754 0.8×	750 1.6×	39	3.5k
Ven Natarajan United States	26	1.7k 0.9×	1.2k 0.8×	892 1.0×	531 0.6×	369 0.8×	56	2.6k

Countries citing papers authored by John Spritzler

Since Specialization

Citations

This map shows the geographic impact of John Spritzler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Spritzler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Spritzler more than expected).

Fields of papers citing papers by John Spritzler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Spritzler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Spritzler. The network helps show where John Spritzler may publish in the future.

Co-authorship network of co-authors of John Spritzler

This figure shows the co-authorship network connecting the top 25 collaborators of John Spritzler. A scholar is included among the top collaborators of John Spritzler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Spritzler. John Spritzler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Jonathan Z., et al.. (2012). Evaluation of HIV-1 Ambiguous Nucleotide Frequency During Antiretroviral Treatment Interruption. JAIDS Journal of Acquired Immune Deficiency Syndromes. 61(1). 19–22. 3 indexed citations

Li, Jonathan Z., Zabrina L. Brumme, Chanson J. Brumme, et al.. (2011). Factors Associated With Viral Rebound in HIV-1-Infected Individuals Enrolled in a Therapeutic HIV-1 gag Vaccine Trial. The Journal of Infectious Diseases. 203(7). 976–983. 21 indexed citations

Crawford, Keith W., John Spritzler, Robert C. Kalayjian, et al.. (2010). Age-Related Changes in Plasma Concentrations of the HIV Protease Inhibitor Lopinavir. AIDS Research and Human Retroviruses. 26(6). 635–643. 29 indexed citations

Skowron, Gail, John Spritzler, Jodi Weidler, et al.. (2009). Replication Capacity in Relation to Immunologic and Virologic Outcomes in HIV-1-Infected Treatment-Naive Subjects. JAIDS Journal of Acquired Immune Deficiency Syndromes. 50(3). 250–258. 4 indexed citations

Spritzler, John, et al.. (2008). Two-Sample Tests of Area-Under-the-Curve in the Presence of Missing Data. The International Journal of Biostatistics. 4(1). Article 1–Article 1. 15 indexed citations

Gandhi, Rajesh T., John Spritzler, Ellen S. Chan, et al.. (2006). Effect of Baseline- and Treatment-Related Factors on Immunologic Recovery After Initiation of Antiretroviral Therapy in HIV-1-Positive Subjects. JAIDS Journal of Acquired Immune Deficiency Syndromes. 42(4). 426–434. 133 indexed citations

Kalayjian, Robert C., John Spritzler, Minya Pu, et al.. (2005). Distinct Mechanisms of T Cell Reconstitution Can Be Identified by Estimating Thymic Volume in Adult HIV‐1 Disease. The Journal of Infectious Diseases. 192(9). 1577–1587. 30 indexed citations

Borucki, Michael J., John Spritzler, David M. Asmuth, et al.. (2004). A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus retinitis. Antiviral Research. 64(2). 103–111. 27 indexed citations

Spritzler, John, Donna Mildvan, Daniella Livnat, et al.. (2003). Can Immune Markers Predict Subsequent Discordance between Immunologic and Virologic Responses to Antiretroviral Therapy? Adult AIDS Clinical Trials Group. Clinical Infectious Diseases. 37(4). 551–558. 17 indexed citations

10.

Valdez, Hernán, Ronald T. Mitsuyasu, Alan Landay, et al.. (2003). Interleukin‐2 Increases CD4⁺Lymphocyte Numbers but Does Not Enhance Responses to Immunization: Results of A5046s. The Journal of Infectious Diseases. 187(2). 320–325. 43 indexed citations

11.

Wallis, Robert S., Robert C. Kalayjian, Jeffrey M. Jacobson, et al.. (2003). A Study of the Immunology, Virology, and Safety of Prednisone in HIV-1–Infected Subjects with CD4 Cell Counts of 200 to 700 mm−3. JAIDS Journal of Acquired Immune Deficiency Syndromes. 32(3). 281–286. 39 indexed citations

12.

Kalayjian, Robert C., Alan Landay, Richard B. Pollard, et al.. (2003). Age‐Related Immune Dysfunction in Health and in Human Immunodeficiency Virus (HIV) Disease: Association of Age and HIV Infection with Naive CD8⁺Cell Depletion, Reduced Expression of CD28 on CD8⁺Cells, and Reduced Thymic Volumes. The Journal of Infectious Diseases. 187(12). 1924–1933. 121 indexed citations

13.

Landay, Alan, Ellen S. Chan, John Spritzler, et al.. (2002). Evidence of Immune Reconstitution in Antiretroviral Drug-Experienced Patients with Advanced HIV Disease. AIDS Research and Human Retroviruses. 18(2). 95–102. 29 indexed citations

14.

Wu, Hulin, Elizabeth Connick, Daniel R. Kuritzkes, et al.. (2001). Multiple CD4 ⁺ Cell Kinetic Patterns and Their Relationships with Baseline Factors and Virological Responses in HIV Type 1 Patients Receiving Highly Active Antiretroviral Therapy. AIDS Research and Human Retroviruses. 17(13). 1231–1240. 17 indexed citations

15.

Al‐Harthi, Lena, et al.. (2000). Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease. AIDS. 14(7). 761–770. 81 indexed citations

16.

Kuritzkes, Daniel R., Anne Sevin, Benjamin Young, et al.. (2000). Effect of Zidovudine Resistance Mutations on Virologic Response to Treatment with Zidovudine‐Lamivudine‐Ritonavir: Genotypic Analysis of Human Immunodeficiency Virus Type 1 Isolates from AIDS Clinical Trials Group Protocol 315. The Journal of Infectious Diseases. 181(2). 491–497. 35 indexed citations

17.

MacArthur, Rodger D., Michael M. Lederman, Constance A. Benson, et al.. (2000). Effects ofMycobacterium aviumComplex–Infection Treatment on Cytokine Expression in Human Immunodeficiency Virus–Infected Persons: Results of AIDS Clinical Trials Group Protocol 853. The Journal of Infectious Diseases. 181(4). 1486–1490. 7 indexed citations

18.

Kaushal, Sumesh, Alan Landay, Michael M. Lederman, et al.. (1999). Increases in T Cell Telomere Length in HIV Infection after Antiretroviral Combination Therapy for HIV-1 Infection Implicate Distinct Population Dynamics in CD4+ and CD8+ T Cells. Clinical Immunology. 92(1). 14–24. 29 indexed citations

19.

Jacobson, Jeffrey M., John Spritzler, Lawrence K. Fox, et al.. (1999). Thalidomide for the Treatment of Esophageal Aphthous Ulcers in Patients with Human Immunodeficiency Virus Infection. The Journal of Infectious Diseases. 180(1). 61–67. 59 indexed citations

20.

Lederman, Michael M., Elizabeth Connick, Alan Landay, et al.. (1998). Immunologic Responses Associated with 12 Weeks of Combination Antiretroviral Therapy Consisting of Zidovudine, Lamivudine, and Ritonavir: Results of AIDS Clinical Trials Group Protocol 315. The Journal of Infectious Diseases. 178(1). 70–79. 354 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact